Teva Pharmaceuticals USA, based in Parsippany, New Jersey, issued a voluntary recall on Oct. 7 for some of the prazosin ...

Evaluate the expected performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining ...

The U.S. Food and Drug Administration recalled more than 580,000 bottles of a blood pressure medication. Is your medication ...

Key market opportunities in the pharma 5 sector include leveraging digital health technologies, AI-driven drug discovery, and ...

Key Points Israel-based Phoenix Financial acquired more than 3.5 million additional shares of Teva Pharmaceuticals for an estimated $62.1 million in the third quarter. Post-transaction, the fund ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

The Food and Drug Administration (FDA) just announced that over 580,000 bottles of blood pressure medications made by Teva ...

Imagine reaching for your daily medication, only to learn it could be putting your health at risk. That's the reality facing ...

Alvotech, with its strategic commercialisation partner Advanz Pharma, received EMA approval for Mynzepli (AVT06) in August ...

The main Irish arm of Israeli-headquartered pharmaceutical firm Teva last year paid out dividends of $709.5 million (€617.9 ...

Teva has issued a voluntary recall of more than 500,000 bottles of the widely used blood pressure medication prazosin ...

Teva Pharmaceuticals USA, issued a voluntary recall on Oct. 7 for approximately 580,000 bottles of blood pressure medication ...